glp-1 drugs and dementia In New Trials, Ozempic's 'Miracle Drug' Image Takes a Hit GLP-1 Drug Fails to Quell
Description
The higher dose also achieved slightly better glycemic control, reductions in cardiometabolic risk, and improved physical function relative to the standard dose

These reports are clinically important because aspiration is uncommon but potentially serious, and anesthesia suppresses protective airway reflexes

For instance, a meta-analysis demonstrated that SGLT2i/GLP-1 RA combination therapy lowered the incidence of HF and major adverse cardiac and cerebrovascular events more effectively than either agent alone [96]

doi:10.2337/dcS13-2015 109

In terms of bloating, 4 studies (with 229 subjects from each of the groups) were included for analysis
:max_bytes(150000):strip_icc()/VWH-How-could-GLP-1s-impact-dementia-AD-FINAL-a0c8263ef12141919ca453be8a96d22b.jpg)
10.1016/j.tins.2009.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar] Holscher C
